The objective of this study was to examine whether white-matter (WM) connectivity of patients with schizophrenia at early stage of treatment is related to treatment response after paliperidone extended-release (ER) treatment. Forty-one patients with schizophrenia and 17 age- and sex-matched healthy control subjects were included in this study. Brain magnetic resonance scans at 3 Tesla were conducted at early stage of treatment. Voxel-wise statistical analysis of the fractional anisotropy (FA) data was performed using Tract-Based Spatial Statistics. At baseline and eight weeks after paliperidone treatment, patients were assessed using the Positive and Negative Syndrome Scale, the Scale for the Assessment of Positive Symptoms and the Scale for the Assessment of Negative Symptoms. Among the patients with schizophrenia, the FA values of the corpus callosum, corona radiata, internal capsule, external capsule, superior longitudinal fasciculus and fronto-temporal WM regions showed significant negative correlations with scores of the treatment response. The current study suggests that the treatment response after paliperidone ER treatment may be associated with the fronto-temporo-limbic WM connectivity at early stage of treatment in patients with schizophrenia, and it could be used as a predictor of treatment response to paliperidone ER treatment after studies with large samples verify these results.
AndreasenNC (1984) Scale for the Assessment of University of Iowa Positive Symptoms: (SAPS). Iowa City, IA: University of Iowa.
2.
AndreasenNC (1989) The Scale for the Assessment of Negative Symptoms (SANS): conceptual and theoretical foundations. Br J Psychiatry Suppl (7): 49–58.
3.
AndreasenNCCarpenterWTJrKaneJM. (2005) Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry162: 441–449.
4.
BartzokisG (2012) Neuroglialpharmacology: myelination as a shared mechanism of action of psychotropic treatments. Neuropharmacology62: 2137–2153.
5.
BartzokisGLuPHNuechterleinKH. (2007) Differential effects of typical and atypical antipsychotics on brain myelination in schizophrenia. Schizophr Res93: 13–22.
6.
BridlerRUmbrichtD (2003) Atypical antipsychotics in the treatment of schizophrenia. Swiss Med Wkly133: 63–76.
7.
CamchongJMacdonaldAW3rdBellC. (2011) Altered functional and anatomical connectivity in schizophrenia. Schizophr Bull37: 640–650.
8.
CanuEAgostaFFilippiM (2015) A selective review of structural connectivity abnormalities of schizophrenic patients at different stages of the disease. Schizophr Res161: 19–28.
9.
CanusoCMBossieCATurkozI. (2009) Paliperidone extended-release for schizophrenia: effects on symptoms and functioning in acutely ill patients with negative symptoms. Schizophr Res113: 56–64.
10.
CarmanJPeuskensJVangeneugdenA (1995) Risperidone in the treatment of negative symptoms of schizophrenia: a meta-analysis. Int Clin Psychopharmacol10: 207–213.
11.
ChwiedukCMKeatingGM (2010) Paliperidone extended release: a Review of its use in the management of schizophrenia. Drugs70: 1295–1317.
12.
DavidsonMEmsleyRKramerM. (2007) Efficacy, safety and early response of paliperidone extended-release tablets (Paliperidone ER): results of a 6-week, randomized, placebo-controlled study. Schizophr Res93: 117–130.
13.
DavisKLStewartDGFriedmanJI. (2003) White matter changes in schizophrenia: evidence for myelin-related dysfunction. Arch Gen Psychiatry60: 443–456.
14.
De LacosteMCKirkpatrickJBRossED (1985) Topography of the human corpus callosum. J Neuropathol Exp Neurol44: 578–591.
15.
Ellison-WrightIBullmoreE (2009) Meta-analysis of diffusion tensor imaging studies in schizophrenia. Schizophr Res108: 3–10.
16.
FilippiMCanuEGasparottiR. (2014) Patterns of brain structural changes in first-contact, antipsychotic drug-naive patients with schizophrenia. AJNR Am J Neuroradiol35: 30–37.
17.
GarverDLHolcombJAChristensenJD (2008) Compromised myelin integrity during psychosis with repair during remission in drug-responding schizophrenia. Int J Neuropsychopharmacol11: 49–61.
18.
GuillinOAbi-DarghamALaruelleM (2007) Neurobiology of dopamine in schizophrenia. Int Rev Neurobiol78: 1–39.
19.
HaroJMKamathSAOchoaS. (2003) The Clinical Global Impression-Schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia. Acta Psychiatr Scand Suppl (416): 16–23.
20.
HoBCAndreasenNCZiebellS. (2011) Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. Arch Gen Psychiatry68: 128–137.
21.
HuangMWYangTTTenPR. (2012) Effects of paliperidone extended release on the symptoms and functioning of schizophrenia. BMC Clin Pharmacol12: 1.
22.
KaneJCanasFKramerM. (2007) Treatment of schizophrenia with paliperidone extended-release tablets: a 6-week placebo-controlled trial. Schizophr Res90: 147–161.
23.
KarlsgodtKHNiendamTABeardenCE. (2009) White matter integrity and prediction of social and role functioning in subjects at ultra-high risk for psychosis. Biol Psychiatry66: 562–569.
24.
KaySROplerLALindenmayerJP (1989) The Positive and Negative Syndrome Scale (PANSS): rationale and standardisation. Br J Psychiatry Suppl (7): 59–67.
25.
KochKWagnerGDahnkeR. (2010) Disrupted white matter integrity of corticopontine-cerebellar circuitry in schizophrenia. Eur Arch Psychiatry Clin Neurosci260: 419–426.
26.
KubickiMMccarleyRWestinCF. (2007) A review of diffusion tensor imaging studies in schizophrenia. J Psychiatr Res41: 15–30.
27.
LahtiACWeilerMAHolcombHH. (2009) Modulation of limbic circuitry predicts treatment response to antipsychotic medication: a functional imaging study in schizophrenia. Neuropsychopharmacology34: 2675–2690.
28.
LeeSHKubickiMAsamiT. (2013) Extensive white matter abnormalities in patients with first-episode schizophrenia: a diffusion tensor imaging (DTI) study. Schizophr Res143: 231–238.
29.
LuckDBuchyLCzechowskaY. (2011) Fronto-temporal disconnectivity and clinical short-term outcome in first episode psychosis: a DTI-tractography study. J Psychiatr Res45: 369–377.
30.
MarinoJCaballeroJ (2008) Paliperidone extended-release for the treatment of schizophrenia. Pharmacotherapy28: 1283–1298.
31.
MitelmanSACanfieldELNewmarkRE. (2009) Longitudinal assessment of gray and white matter in chronic schizophrenia: a combined diffusion-tensor and structural magnetic resonance imaging study. Neuroimage3: 31–47.
32.
MitelmanSANewmarkRETorosjanY. (2006) White matter fractional anisotropy and outcome in schizophrenia. Schizophr Res87: 138–159.
33.
MolinaVReigSSanzJ. (2005) Increase in gray matter and decrease in white matter volumes in the cortex during treatment with atypical neuroleptics in schizophrenia. Schizophr Res80: 61–71.
34.
NicholsTEHolmesAP (2002) Nonparametric permutation tests for functional neuroimaging: a primer with examples. Hum Brain Mapp15: 1–25.
35.
Reis MarquesTTaylorHChaddockC. (2014) White matter integrity as a predictor of response to treatment in first episode psychosis. Brain137: 172–182.
36.
SamartzisLDimaDFusar-PoliP. (2014) White matter alterations in early stages of schizophrenia: a systematic review of diffusion tensor imaging studies. J Neuroimaging24: 101–110.
37.
SeokJHParkHJChunJW. (2007) White matter abnormalities associated with auditory hallucinations in schizophrenia: a combined study of voxel-based analyses of diffusion tensor imaging and structural magnetic resonance imaging. Psychiatry Res156: 93–104.
38.
ServantDBaillyDAllardC. (1991) Major depression in panic disorder: role of recent life events. J Affect Disord22: 79–82.
39.
ShergillSSKanaanRAChitnisXA. (2007) A diffusion tensor imaging study of fasciculi in schizophrenia. Am J Psychiatry164: 467–473.
SmithSMNicholsTE (2009) Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference. Neuroimage44: 83–98.
43.
SzeszkoPRGoldbergEGunduz-BruceH. (2003) Smaller anterior hippocampal formation volume in antipsychotic-naive patients with first-episode schizophrenia. Am J Psychiatry160: 2190–2197.
44.
SzeszkoPRNarrKLPhillipsOR. (2012) Magnetic resonance imaging predictors of treatment response in first-episode schizophrenia. Schizophr Bull38: 569–578.
45.
Van Den HeuvelMPMandlRCStamCJ. (2010) Aberrant frontal and temporal complex network structure in schizophrenia: a graph theoretical analysis. J Neurosci30: 15915–15926.
46.
Van VeelenNMVinkMRamseyNF. (2011) Prefrontal lobe dysfunction predicts treatment response in medication-naive first-episode schizophrenia. Schizophr Res129: 156–162.
47.
WiersmaDNienhuisFJSlooffCJ. (1998) Natural course of schizophrenic disorders: a 15-year followup of a Dutch incidence cohort. Schizophr Bull24: 75–85.
48.
WolkinAChoiSJSzilagyiS. (2003) Inferior frontal white matter anisotropy and negative symptoms of schizophrenia: a diffusion tensor imaging study. Am J Psychiatry160: 572–574.
49.
ZhangYZhangHWangL. (2012) Quetiapine enhances oligodendrocyte regeneration and myelin repair after cuprizone-induced demyelination. Schizophr Res138: 8–17.
